Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease

por Martini, Dylan J, Chen, Yi-Bin, DeFilipp, Zachariah
Publicado 2022

Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

por Olsen, T. Anders, Martini, Dylan J., Evans, Sean T., Goldman, Jamie M., Bilen, Mehmet Asim
Publicado 2021

African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center

por Martini, Dylan J., Goyal, Subir, Switchenko, Jeffrey M., Lechowicz, Mary Jo, Allen, Pamela B.
Publicado 2022

Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma

por Martini, Dylan J., Jansen, Caroline S., Harik, Lara R., Evans, Sean T., Olsen, T. Anders, Master, Viraj A., Kissick, Haydn T., Bilen, Mehmet Asim
Publicado 2021

Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions

por Karabachev, Alexander D., Martini, Dylan J., Hermel, David J., Solcz, Dana, Richardson, Marcy E., Pesaran, Tina, Sarkar, Indra Neil, Greenblatt, Marc S.
Publicado 2020

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series

por Martini, Dylan J., Lalani, Aly-Khan A., Bossé, Dominick, Steinharter, John A., Harshman, Lauren C., Hodi, F. Stephen, Ott, Patrick A., Choueiri, Toni K.
Publicado 2017

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy

por Olsen, T. Anders, Zhuang, Tony Zibo, Caulfield, Sarah, Martini, Dylan J., Brown, Jacqueline T., Carthon, Bradley C., Kucuk, Omer, Harris, Wayne, Bilen, Mehmet Asim, Nazha, Bassel
Publicado 2022

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

por Zhuang, Tony Z, Ravindranathan, Deepak, Liu, Yuan, Martini, Dylan J, Brown, Jacqueline T, Nazha, Bassel, Russler, Greta, Yantorni, Lauren B, Caulfield, Sarah, Carthon, Bradley C, Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Publicado 2022

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

por Martini, Dylan J., Liu, Yuan, Shabto, Julie M., Carthon, Bradley C., Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Publicado 2019

Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma

por Schmeusser, Benjamin N., Patil, Dattatraya H., Midenberg, Eric, Higgins, Michelle I., Zaldumbide, Joel, Martini, Dylan J., Steele, Sean, Williams, Milton, Nabavizadeh, Reza, Psutka, Sarah P., Ogan, Kenneth, Bilen, Mehmet Asim, Master, Vraj A.
Publicado 2022

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

por Lalani, Aly-Khan A., Xie, Wanling, Martini, Dylan J., Steinharter, John A., Norton, Craig K., Krajewski, Katherine M., Duquette, Audrey, Bossé, Dominick, Bellmunt, Joaquim, Van Allen, Eliezer M., McGregor, Bradley A., Creighton, Chad J., Harshman, Lauren C., Choueiri, Toni K.
Publicado 2018

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

por Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Ravindranathan, Deepak, Brown, Jacqueline, Hitron, Emilie E., Russler, Greta A., Caulfield, Sarah, Kissick, Haydn, Alemozaffar, Mehrdad, Ogan, Kenneth, Harris, Wayne B., Master, Viraj A., Kucuk, Omer, Carthon, Bradley C., Bilen, Mehmet A.
Publicado 2020

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

por Olsen, T. Anders, Martini, Dylan J., Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Nazha, Bassel, Bilen, Mehmet Asim
Publicado 2021

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

por Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Nazha, Bassel, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Bilen, Mehmet Asim
Publicado 2021

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

por Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Hitron, Emilie Elise, Russler, Greta Anne, Yantorni, Lauren, Caulfield, Sarah, Brown, Jacqueline T., Goldman, Jamie M., Nazha, Bassel, Carthon, Bradley C., Harris, Wayne B., Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Publicado 2022

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

por Brown, Jacqueline T, Liu, Yuan, Shabto, Julie M, Martini, Dylan, Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren, Joshi, Shreyas Subhash, Kissick, Haydn, Ogan, Kenneth, Nazha, Bassel, Carthon, Bradley C, Kucuk, Omer, Harris, Wayne B, Master, Viraj A, Bilen, Mehmet Asim
Publicado 2021

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

por Abou Alaiwi, Sarah, Xie, Wanling, Nassar, Amin H, Dudani, Shaan, Martini, Dylan, Bakouny, Ziad, Steinharter, John A, Nuzzo, Pier Vitale, Flippot, Ronan, Martinez-Chanza, Nieves, Wei, Xiao, McGregor, Bradley A, Kaymakcalan, Marina D, Heng, Daniel Y C, Bilen, Mehmet A, Choueiri, Toni K, Harshman, Lauren C
Publicado 2020

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

por Bilen, Mehmet Asim, Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Lewis, Colleen, Collins, Hannah, Akce, Mehmet, Kissick, Haydn, Carthon, Bradley C., Shaib, Walid L., Alese, Olatunji B., Steuer, Conor E., Wu, Christina, Lawson, David H., Kudchadkar, Ragini, Master, Viraj A., El-Rayes, Bassel, Ramalingam, Suresh S., Owonikoko, Taofeek K., Harvey, R. Donald
Publicado 2019

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas

por Thouvenin, Jonathan, Alhalabi, Omar, Carlo, Maria, Carril-Ajuria, Lucia, Hirsch, Laure, Martinez-Chanza, Nieves, Négrier, Sylvie, Campedel, Luca, Martini, Dylan, Borchiellini, Delphine, Chahoud, Jad, Lodi, Massimo, Barthélémy, Philippe, Hasanov, Elshad, Hahn, Andrew W, Gil, Thierry, Viswanathan, Srinivas R, Bakouny, Ziad, Msaouel, Pavlos, Asim Bilen, Mehmet, Choueiri, Toni K, Albiges, Laurence, Tannir, Nizar M, Malouf, Gabriel G
Publicado 2022

Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy

por Bilen, Mehmet Asim, Martini, Dylan J., Liu, Yuan, Shabto, Julie M., Brown, Jacqueline T., Williams, Milton, Khan, Amir I., Speak, Alexandra, Lewis, Colleen, Collins, Hannah, Kissick, Haydn T., Carthon, Bradley C., Akce, Mehmet, Shaib, Walid L., Alese, Olatunji B., Pillai, Rathi N., Steuer, Conor E., Wu, Christina S., Lawson, David H., Kudchadkar, Ragini R., El‐Rayes, Bassel F., Ramalingam, Suresh S., Owonikoko, Taofeek K., Harvey, R. Donald, Master, Viraj A.
Publicado 2019